233 related articles for article (PubMed ID: 12738699)
1. GP and patient predictors of PSA screening in Australian general practice.
Gattellari M; Young JM; Ward JE
Fam Pract; 2003 Jun; 20(3):294-303. PubMed ID: 12738699
[TBL] [Abstract][Full Text] [Related]
2. Will men attribute fault to their GP for adverse effects arising from controversial screening tests? An Australian study using scenarios about PSA screening.
Gattellari M; Ward JE
J Med Screen; 2004; 11(4):165-9. PubMed ID: 15563771
[TBL] [Abstract][Full Text] [Related]
3. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
4. Men's reactions to disclosed and undisclosed opportunistic PSA screening for prostate cancer.
Gattellari M; Ward JE
Med J Aust; 2005 Apr; 182(8):386-9. PubMed ID: 15850434
[TBL] [Abstract][Full Text] [Related]
5. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
Gattellari M; Ward JE
J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
[TBL] [Abstract][Full Text] [Related]
6. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
7. The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study.
Clements A; Watson E; Rai T; Bukach C; Shine B; Austoker J
BMC Fam Pract; 2007 Jun; 8():35. PubMed ID: 17593306
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
Williams N; Hughes LJ; Turner EL; Donovan JL; Hamdy FC; Neal DE; Martin RM; Metcalfe C
BJU Int; 2011 Nov; 108(9):1402-8. PubMed ID: 21481132
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS.
Weller D; Pinnock C; Silagy C; Hiller JE; Marshall VR
Aust N Z J Public Health; 1998; 22(3 Suppl):400-2. PubMed ID: 9629831
[TBL] [Abstract][Full Text] [Related]
10. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study.
Young GJ; Harrison S; Turner EL; Walsh EI; Oliver SE; Ben-Shlomo Y; Evans S; Lane JA; Neal DE; Hamdy FC; Donovan JL; Martin RM; Metcalfe C
BMJ Open; 2017 Oct; 7(10):e017729. PubMed ID: 29084797
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
[TBL] [Abstract][Full Text] [Related]
13. PSA testing in general practice.
Hodgson F; Obertová Z; Brown C; Lawrenson R
J Prim Health Care; 2012 Sep; 4(3):199-204. PubMed ID: 22946067
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
Jønler M; Eddy B; Poulsen J
Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
17. Does 'peer coaching' increase GP capacity to promote informed decision making about PSA screening? A cluster randomised trial.
Gattellari M; Donnelly N; Taylor N; Meerkin M; Hirst G; Ward JE
Fam Pract; 2005 Jun; 22(3):253-65. PubMed ID: 15824055
[TBL] [Abstract][Full Text] [Related]
18. Cervical screening among immigrant Vietnamese women seen in general practice: current rates, predictors and potential recruitment strategies.
Lesjak M; Hua M; Ward J
Aust N Z J Public Health; 1999 Apr; 23(2):168-73. PubMed ID: 10330732
[TBL] [Abstract][Full Text] [Related]
19. GPs views and understanding of PSA testing, screening and early detection; survey.
Sutton J; Melia J; Kirby M; Graffy J; Moss S
Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
[TBL] [Abstract][Full Text] [Related]
20. Self-reported prevalence of prostate-specific antigen testing in South Australia: a community study.
Pinnock CB; Weller DP; Marshall VR
Med J Aust; 1998 Jul; 169(1):25-8. PubMed ID: 9695698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]